Huisheng Biotech Pharmaceu
Huisheng Biotech Pharmaceutical Co., Ltd., commonly referred to as Huisheng Biotech, is a prominent player in the biopharmaceutical industry, headquartered in China (CN). Established in 2001, the company has made significant strides in the development and production of innovative biopharmaceutical products, focusing on areas such as oncology, autoimmune diseases, and infectious diseases. With a robust operational presence across Asia and expanding into global markets, Huisheng Biotech is renowned for its cutting-edge biologics and biosimilars. The company’s core offerings include monoclonal antibodies and recombinant proteins, distinguished by their high efficacy and safety profiles. Recognised for its commitment to quality and research excellence, Huisheng Biotech has achieved notable milestones, positioning itself as a trusted name in the biopharmaceutical sector.
DitchCarbon Score
How does Huisheng Biotech Pharmaceu's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Huisheng Biotech Pharmaceu's score of 15 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Huisheng Biotech Pharmaceu's reported carbon emissions
Huisheng Biotech Pharmaceutical, headquartered in CN, currently does not provide specific carbon emissions data or reduction targets. Without available emissions figures, it is challenging to assess their carbon footprint or climate commitments accurately. The absence of documented reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, Huisheng Biotech may need to establish clear targets and initiatives to align with global climate goals and enhance its environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Huisheng Biotech Pharmaceu is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
